Unknown PHASE3 INTERVENTIONAL 2-arm NCT00552942

Randomized Controlled Trial of Laparoscopic Gastric Bypass Plus Omentectomy Versus Laparoscopic Gastric Bypass Alone in Improving Diabetic Indices

Sponsor: Legacy Health System

Conditions Cytokines Diabetes Interleukins

Interventions laparoscopic gastric bypass plus omentectomy

Updated 4 times since 2017 Last updated: Nov 1, 2007 Started: Jul 31, 2006 Completion: Jul 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cytokines and Diabetes and is currently ongoing. Legacy Health System leads this study, which shows 4 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE3

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Legacy Health System

Data source: Legacy Health System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Portland, United States